Our Therapies

The first and only FDA-approved
treatment for Demodex blepharitis

Financials

SEC Filings

Filing date Form Description View
10-K Annual report which provides a comprehensive overview of the company for the past year EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
S-8 Securities offered to employees pursuant to employee benefit plans XML - XBRL INSTANCE DOCUMENT View HTML
3 Initial filing by director officer or owner of more than ten percent View HTML
4 Statement of changes in beneficial ownership of securities View HTML
8-K Report of unscheduled material events or corporate event EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
SCHEDULE 13G/A SCHEDULE 13G/A - Description View HTML
4 Statement of changes in beneficial ownership of securities View HTML
8-K Report of unscheduled material events or corporate event EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
4 Statement of changes in beneficial ownership of securities View HTML
144 Filed by "insiders" prior intended sale of restricted stock. View HTML

 

Anchor Link for Quarterly Results

Data provided by Kaleidoscope.